Charles Bensenhaver, MD
Psychiatry · Louisville, KYNPI 1215031646
Payments from drug & device makers
Across 47 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$169
- Johnson & Johnson$125
- Vanda Pharmaceuticals Inc.$109
- Bausch Health US, LLC$95
- Corium, LLC$84
- Takeda Pharmaceuticals U.S.A., Inc.$29
- plus $169 from 9 others
What the payments were for
- Food & beverage$780100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $169 |
| Johnson & Johnson | 7 | $125 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| Bausch Health US, LLC | 6 | $95 |
| Corium, LLC | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 2 | $27 |
| Neos Therapeutics, LP | 2 | $27 |
| Alkermes, Inc. | 1 | $16 |
| Indivior Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Tempus AI, Inc | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $11 |
How this compares
$780 in reported general payments places this provider in the 60th percentile of 348 psychiatry providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LatudaLurasidone Hcl | 12 | $16,179 |
| CymbaltaDuloxetine Hcl | 15 | $8,215 |
| Lisdexamfetamine Dimesylate | 17 | $3,034 |
| Aripiprazole | 67 | $2,714 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 99 | $2,256 |
| Bupropion XlBupropion Hcl | 83 | $2,225 |
| Desipramine Hcl | 20 | $2,002 |
| Divalproex Sodium ErDivalproex Sodium | 90 | $1,733 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $1,425 |
| Olanzapine | 92 | $1,273 |
| Lamotrigine | 154 | $1,239 |
| Duloxetine Hcl | 77 | $1,225 |
| Quetiapine Fumarate | 76 | $1,167 |
| Vilazodone Hcl | 19 | $1,157 |
| Zolpidem Tartrate ErZolpidem Tartrate | 30 | $1,152 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Louisville
- Rifaat El-MallakhLouisville$1.7M
- Robert StewartLouisville$651K
- Ali FarooquiLouisville$393K
- Stephanie HallLouisville$106K
- Kelly ClarkLouisville$14K
- Michael HarrisLouisville$13K
- Yelena VaninaLouisville$12K
- Mohamed KhodeirLouisville$9K
- Kevin BaysLouisville$9K
- Terry HaganLouisville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.